![](/img/cover-not-exists.png)
Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twenty-Four–Week Results of an Uncontrolled Open-Label Clinical Study
Andrew A. Moshfeghi, Philip J. Rosenfeld, Carmen A. Puliafito, Stephan Michels, Erin N. Marcus, Joshua D. Lenchus, Anna S. VenkatramanVolume:
113
Year:
2006
Language:
english
DOI:
10.1016/j.ophtha.2006.05.070
File:
PDF, 2.84 MB
english, 2006